Ion channel screening: Advances in technologies and analysis

Frontiers in Pharmacology

Volumn 3 MAY, Issue , 2012, Pages

  Martina, Marzia ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUNGAROTOXIN RECEPTOR; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; G PROTEIN COUPLED RECEPTOR; ION CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL HERG; UNCLASSIFIED DRUG; VU 573;

ARTICLE; CELL COMMUNICATION; DEGENERATIVE DISEASE; DRUG COST; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; DRUG TARGETING; HEART MUSCLE CONDUCTION SYSTEM; HETEROLOGOUS EXPRESSION; HIGH THROUGHPUT SCREENING; HUMAN; LABORATORY AUTOMATION; NERVE CELL MEMBRANE POTENTIAL; NERVE CELL NETWORK; PATCH CLAMP; PROTEIN ANALYSIS;

EID: 84866038652     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00086     Document Type: Article

References (14)

1. Clare, J. J. (2010). Targeting ion channels for drug discovery. Discov. Med. 9, 253-260.
2. Hamill, O. P., Marty, A., Neher, E., Sakmann, B., and Sigworth, F. J. (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391, 85-100.
3. Kaczorowski, G. J., Garcia, M. L., Bode, J., Hess, S. D., and Patel, U. A. (2011). The importance of being profiled: improving drug candidate safety and efficacy using ion channel profiling. Front. Pharmacol. 2:78. doi: 10.3389/ fphar.2011.00078
4. Kaestner, L., and Lipp, P. (2011). Screening action potentials: the power of light. Front. Pharmacol. 2:42. doi: 10.3389/ fphar.2011.00042
5. Möller, C., and Witchel, H. (2011). Automated electrophysiology makes the pace for cardiac ion channel safety screening. Front. Pharmacol. 2:73. doi: 10.3389/fphar.2011.00073
6. Nagarah, J. M. (2011). Neurons on a chip - toward high throughput network and pharmacology investigations. Front. Pharmacol. 2:74. doi: 10.33989/ fphar.2011.00074
7. Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., and Schacht, A. L. (2010). How to improve R&D produc- tivity: the pharmaceutical industry's grand challenge. Nat. Rev. Drug Discov. 9, 203-214.
8. Polonchuk, L. (2012). Toward a new gold standard for early safety: automated temperature-controlled hERG test on the PatchLiner®. Front. Pharmacol. 2:3. doi: 10.3389/fphar.2012.00003
9. Py, C., Martina, M., Diaz-Quijada, G. A., Luk, C. C., Martinez, D., Denhoff, M. D., Charrier, A., Comas, T., Monette, R., Krantis, A., Syed, N. I., and Mealing, G. A. R. (2011). From understanding cel- lular function to novel drug discovery: the role of planar patch-clamp array chip technology. Front. Pharmacol. 2:51. doi: 10.3389/fphar.2011.00051
10. Raphemot, R., Lonergan, D. F., Nguyen, T. T., Utley, T., Lewis, L. L., Kadakia, R., Weaver, C. D., Gogliotti, R., Hopkins, C., Lindsley, C. W., and Denton, J. S. (2011). Discovery, characterization, and structure-activity relationships of an inhibitor of inward rectifier potassium (Kir) channels with pref- erence for Kir2.3, Kir3.X, and Kir7.1. Front. Pharmacol. 2:75. doi: 10.3389/ fphar.2011.00075
11. Sitzia, F., Brown, J. T., Randall, A. D., and Dunlop, J. (2011). Voltage- and temperature-dependent allosteric modulation of α7 nicotinic receptors by PNU120596. Front. Pharmacol. 2:81. doi: 10.3389/fphar.2011.00081
12. Stoelzle, S., Obergrussberger, A., Brüggemann, A., Haarmann, C., George, M., Kettenhofen, R., and Fertig, N. (2011). State-of-the-art automated patch clamp devices: heat activation, action potentials, and high throughput in ion channel screening. Front. Pharmacol. 2:76. doi: 10.3389/ fphar.2011.00076
13. Van der Heyden, M. A. G. (2012). Finding inward rectifier channel inhibitors: why and how? Front. Pharmacol. 2:95. doi: 10.3389/fphar.2011.00095
14. Walsh, K. B. (2011). Targeting GIRK channels for the development of new therapeutic agents. Front. Pharmacol. 2:64. doi: 10.3389/fphar.2011.00064